Crossmark

Correction: Exploiting PRMT5 as a target for combination therapy in mantle cell lymphoma characterized by frequent ATM and TP53 mutations

Crossref DOI link: https://doi.org/10.1038/s41408-026-01472-4

Published Online: 2026-04-08

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Che, Yuxuan

Liu, Yang https://orcid.org/0000-0002-1910-8076
Yao, Yixin https://orcid.org/0000-0002-8439-6043
Hill, Holly A. https://orcid.org/0000-0003-3642-1897
Li, Yijing

Cai, Qingsong

Yan, Fangfang

Jain, Preetesh https://orcid.org/0000-0003-2735-168X
Wang, Wei

Rui, Lixin

Wang, Michael https://orcid.org/0000-0001-9748-5486
License Information

Text and Data Mining valid from 2026-04-08

Version of Record valid from 2026-04-08
More Information

Article History

First Online: 8 April 2026